01:47 PM EST, 03/05/2024 (MT Newswires) -- Datasea ( DTSS ) said Tuesday it expects revenue of about $86 million during the fiscal year ended June 30, compared with $7 million a year ago.

Shares surged 74% as intraday trading volume shot up to more than 13.4 million from a daily average of about 1.84 million.

Apogee Therapeutics ( APGE ) shares surged after the drugmaker issued initial results from the phase 1 trial of APG777, prompting a price target raise by Wedbush to $87 from $40.

Shares soared 49% as intraday trading volume climbed to over 4.94 million from a daily average of almost 350,000 shares.

CASI Pharmaceuticals ( CASI ) reported positive interim phase 1 data for BI-1206 in the treatment of relapsed/refractory indolent non-Hodgkin's lymphoma in China.

Shares jumped 9% as intraday trading volume rose to more than 9.17 million versus the stock's daily average of about 47,000.

Price: 9.82, Change: +4.19, Percent Change: +74.42